Skyray Instrument(SZ:300165) Mei Ri Jing Ji Xin Wen·2025-10-25 03:53Group 1 - ST Tianrui held its 17th meeting of the 6th board of directors on October 23, 2025, to review the "Q3 2025 Report" and other documents [1] - For the year 2024, ST Tianrui's revenue composition is as follows: Instrument manufacturing accounts for 64.21%, ecological protection and environmental governance accounts for 23.45%, third-party testing services account for 10.42%, and pharmaceutical manufacturing accounts for 1.91% [1] Group 2 - As of the report, ST Tianrui has a market capitalization of 2.3 billion yuan [2] - A well-known brand has made a significant investment of 170 million yuan to acquire 2,000 shares of a target company with a registered capital of only 10,000 Hong Kong dollars, raising questions about the necessity of the acquisition [2]